The Third Circuit recently heard oral argument on the ongoing question regarding the constitutionality of the qui tam provision of the False Claims Act (FCA). The issue arose in United States ex rel. Penelow v. Janssen Products, LP, No. 25-1818 (3d Cir.) — a non-intervened qui tam that went to trial and ultimately led

Mortgage lenders and other entities submitting claims for payment to the federal government should take note of recent case law from the Ninth Circuit emphasizing how private litigants continue to drive litigation under the False Claims Act (FCA), even when the government shows little initiative to proceed (or, in this case, even moves to dismiss).

In a recent blog post, Bradley discussed increased False Claims Act (FCA) enforcement by the Department of Justice (DOJ) aimed at curbing diversity, equity and inclusion (DEI) programs in the private sector. Since then, the administration continues to ramp up regulatory pressures on DEI initiatives. 

On March 26, 2026, President Trump issued another executive

Texas is again aggressively investigating and prosecuting dental and orthodontic fraud, particularly regarding Medicaid billing. In fact, in 2025 Attorney General Ken Paxton stated that the Medicaid Fraud Control Unit (MFCU) is heavily targeting pediatric dental chains that use “paper-only” visits, where the clinic bills for an exam that never actually occurred or was performed

On December 28, 2025, media outlets, including the Wall Street Journal, reported that the Department of Justice (DOJ) had begun investigating large private sector entities for their diversity, equity, and inclusion (DEI) practices. Companies, including Alphabet’s Google and Verizon Communications, have reportedly received civil investigative demands (CIDs) from DOJ relating to DEI practices. To

The Department of Justice announced Friday that it obtained more than $6.8 billion in False Claims Act (FCA) settlements and judgments in the fiscal year ending September 30, 2025 (FY 2025). This is the largest total in a single year in FCA history, easily surpassing the $6.1 billion obtained in 2014.

Both recoveries and the

Addressing an issue of first impression, the First Circuit has clarified the burden to satisfy the knowledge element required in False Claims Act (FCA) cases in the context of laboratory testing and Medicare fraud. The Medicare Act permits reimbursement of diagnostic laboratory tests only if they are “reasonable and necessary” for diagnosis or treatment of

On Friday, the Eleventh Circuit heard oral arguments in United States ex rel. Zafirov v. Florida Medical Associates, LLC regarding the constitutionality of the qui tam provisions in the False Claims Act, which allow private persons, known as relators, to file civil enforcement actions for violations of the FCA. The panel consisted of Trump-appointed Judges

The Department of Justice (DOJ) recently obtained several cybersecurity-related False Claims Act (FCA) settlements totaling more than $50 million dollars. Collectively, these settlements reflect a clear message: Cybersecurity is an enforcement priority for the second Trump administration, and any organization that contracts with the federal government is a potential target.

Background

On June 6, 2025